Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Membrane-Associated, Not Cytoplasmic or Nuclear, FGFR1 Induces Neuronal Differentiation.

Csanaky K, Hess MW, Klimaschewski L.

Cells. 2019 Mar 14;8(3). pii: E243. doi: 10.3390/cells8030243.

2.

Molecular mechanisms underlying the Nephroprotective effects of PACAP in diabetes.

Banki E, Kovacs K, Nagy D, Juhasz T, Degrell P, Csanaky K, Kiss P, Jancso G, Toth G, Tamas A, Reglodi D.

J Mol Neurosci. 2014 Nov;54(3):300-9. doi: 10.1007/s12031-014-0249-z. Epub 2014 Feb 19.

PMID:
24535559
3.

Influence of terminal differentiation and PACAP on the cytokine, chemokine, and growth factor secretion of mammary epithelial cells.

Csanaky K, Doppler W, Tamas A, Kovacs K, Toth G, Reglodi D.

J Mol Neurosci. 2014 Jan;52(1):28-36. doi: 10.1007/s12031-013-0193-3. Epub 2013 Dec 10.

PMID:
24323361
4.

Changes in PACAP immunoreactivity in human milk and presence of PAC1 receptor in mammary gland during lactation.

Csanaky K, Banki E, Szabadfi K, Reglodi D, Tarcai I, Czegledi L, Helyes Z, Ertl T, Gyarmati J, Szanto Z, Zapf I, Sipos E, Shioda S, Tamas A.

J Mol Neurosci. 2012 Nov;48(3):631-7. Epub 2012 Apr 27.

PMID:
22539193
5.

Protective effects of the neuropeptide PACAP in diabetic retinopathy.

Szabadfi K, Atlasz T, Kiss P, Reglodi D, Szabo A, Kovacs K, Szalontai B, Setalo G Jr, Banki E, Csanaky K, Tamas A, Gabriel R.

Cell Tissue Res. 2012 Apr;348(1):37-46. doi: 10.1007/s00441-012-1349-0. Epub 2012 Feb 17.

PMID:
22350850
6.

Presence of pituitary adenylate cyclase activating polypeptide-38 in human plasma and milk.

Borzsei R, Mark L, Tamas A, Bagoly T, Bay C, Csanaky K, Banki E, Kiss P, Vaczy A, Horvath G, Nemeth J, Szauer E, Helyes Z, Reglodi D.

Eur J Endocrinol. 2009 Apr;160(4):561-5. doi: 10.1530/EJE-08-0911. Epub 2009 Jan 27.

PMID:
19174531

Supplemental Content

Loading ...
Support Center